RAFAEL HOLDINGS, INC. Amortization of Intangible Assets
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of Intangible Assets of $32.00 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-04-30 was $32.00K, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-01-31 was $33.00K, a 13.16% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization of intangible assets for the quarter ending 2025-10-31 was $32.00K, a 15.79% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization of intangible assets for the quarter ending 2025-07-31 was $33.00K, a 10.81% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization of intangible assets for fiscal 2025 was $142.00K, a 61.36% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. amortization of intangible assets for fiscal 2024 was $88.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-04-30 | $32.00K 10-Q · filed 2026-06-11 | $65.00K derived: sum of 2 quarters · filed 2026-06-11 | $98.00K 10-Q · filed 2026-06-11 | $130.00K derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2026-01-31 | $33.00K 10-Q · filed 2026-03-16 | $65.00K 10-Q · filed 2026-03-16 | $98.00K derived: sum of 3 quarters · filed 2026-03-16 | $130.00K derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-10-31 | $32.00K 10-Q · filed 2025-12-12 | $65.00K derived: sum of 2 quarters · filed 2025-12-12 | $97.00K derived: sum of 3 quarters · filed 2026-06-11 | $135.00K derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-07-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $65.00K derived: sum of 2 quarters · filed 2026-06-11 | $103.00K derived: sum of 3 quarters · filed 2026-06-11 | $142.00K 10-K · filed 2025-10-29 | ||
| 2025-04-30 | $32.00K 10-Q · filed 2026-06-11 | $70.00K derived: sum of 2 quarters · filed 2026-06-11 | $109.00K 10-Q · filed 2026-06-11 | $145.00K derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-01-31 | $38.00K 10-Q · filed 2026-03-16 | $39.00K 10-Q · filed 2025-03-14 | $77.00K 10-Q · filed 2026-03-16 | $113.00K derived: sum of 3 quarters · filed 2026-03-16 | $164.00K derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | $38.00K 10-Q · filed 2025-12-12 | $75.00K derived: sum of 2 quarters · filed 2025-12-12 | $126.00K derived: sum of 3 quarters · filed 2025-12-12 | $138.00K derived: sum of 4 quarters · filed 2025-12-12 | ||
| 2024-07-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $88.00K derived: sum of 2 quarters · filed 2025-10-29 | $100.00K derived: sum of 3 quarters · filed 2025-10-29 | $88.00K 10-K · filed 2025-10-29 | ||
| 2024-04-30 | $51.00K 10-Q · filed 2025-06-11 | $63.00K derived: sum of 2 quarters · filed 2025-06-11 | $51.00K 10-Q · filed 2025-06-11 | $63.00K 10-Q · filed 2024-06-14 | ||
| 2024-01-31 | $12.00K 10-Q · filed 2025-03-14 | $12.00K 10-Q · filed 2025-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |